{"id":"treosulfan-cytarabine","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Hepatotoxicity"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Infection"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Treosulfan is a bifunctional alkylating agent that cross-links DNA strands, preventing replication and transcription. Cytarabine is a cytidine analog that inhibits DNA synthesis by being incorporated into DNA and blocking chain elongation. Together, they provide complementary mechanisms of cytotoxicity, commonly used in myeloablative conditioning regimens prior to hematopoietic stem cell transplantation.","oneSentence":"Treosulfan and cytarabine work together as a chemotherapy combination that damages DNA in cancer cells, with treosulfan acting as an alkylating agent and cytarabine as a nucleoside analog.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:40:08.995Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Conditioning regimen for hematopoietic stem cell transplantation in acute myeloid leukemia"},{"name":"Conditioning regimen for hematopoietic stem cell transplantation in acute lymphoblastic leukemia"}]},"trialDetails":[{"nctId":"NCT05807932","phase":"PHASE1, PHASE2","title":"Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2023-06-26","conditions":"Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia","enrollment":38},{"nctId":"NCT03961919","phase":"PHASE2","title":"Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant","status":"COMPLETED","sponsor":"Ciceri Fabio","startDate":"2009-02-10","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndromes, Transplant-Related Hematologic Malignancy","enrollment":15},{"nctId":"NCT04000698","phase":"PHASE3","title":"Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias","status":"UNKNOWN","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2019-10-15","conditions":"Refractory Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia","enrollment":25},{"nctId":"NCT00779714","phase":"PHASE3","title":"Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC","status":"UNKNOWN","sponsor":"University of Wuerzburg","startDate":"2008-10","conditions":"Melanoma","enrollment":360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ovastat + alexan"],"phase":"phase_3","status":"active","brandName":"treosulfan + cytarabine","genericName":"treosulfan + cytarabine","companyName":"University of Wuerzburg","companyId":"university-of-wuerzburg","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Treosulfan and cytarabine work together as a chemotherapy combination that damages DNA in cancer cells, with treosulfan acting as an alkylating agent and cytarabine as a nucleoside analog. Used for Conditioning regimen for hematopoietic stem cell transplantation in acute myeloid leukemia, Conditioning regimen for hematopoietic stem cell transplantation in acute lymphoblastic leukemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}